Do TRIB1 and IL-9 Gene Polymorphisms Impact the Development and Manifestation of Pituitary Adenoma?

In Vivo. 2020 Sep-Oct;34(5):2499-2505. doi: 10.21873/invivo.12066.

Abstract

Background/aim: To evaluate the association between TRIB1(rs6987702) and IL-9(rs1859430, rs2069870) genotypes with the development and manifestation of pituitary adenoma (PA).

Materials and methods: The study group included 141 patients with PA and the control group consisted of 287 healthy people. The genotyping of rs6987702, rs1859430 and rs2069870 was carried out using a real-time polymerase chain reaction.

Results: Statistically significant results were obtained regarding the rs1859430, but there were no significant results regarding rs6987702. We found that the rs1859430 A/A genotype increased the odds of having recurrent PA six times (p=0.006) under the co-dominant model and four times (p=0.021) under the recessive model. Furthermore, the analysis showed that the G/A genotype increased the odds of having recurrent PA 2.3 times (p=0.003) under the co-dominant model, while G/A and A/A genotypes increased the odds 2.7 times (p=0.011) under the over-dominant model.

Conclusion: Certain genotypes of rs1859430 can be associated with PA recurrence.

Keywords: IL-9 rs1859430; Pituitary adenoma; TRIB1 rs6987702 gene polymorphism; recurrence; rs2069870 gene polymorphism.

MeSH terms

  • Adenoma* / genetics
  • Case-Control Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Interleukin-9 / genetics*
  • Intracellular Signaling Peptides and Proteins / genetics*
  • Neoplasm Recurrence, Local
  • Pituitary Neoplasms* / genetics
  • Polymorphism, Single Nucleotide
  • Protein Serine-Threonine Kinases / antagonists & inhibitors

Substances

  • IL9 protein, human
  • Interleukin-9
  • Intracellular Signaling Peptides and Proteins
  • TRIB1 protein, human
  • Protein Serine-Threonine Kinases